Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HKT-500
- Development stage
- Discontinued
- Lead developer
- Hisamitsu Pharmaceutical
- Modality
- Small Molecules
- Administration
- Topical, Transdermal
01
Overview
HKT-500 is a topical analgesic patch containing ketoprofen developed by Hisamitsu Pharmaceutical. It was designed as an external-use pain-relieving patch for various pain conditions including ankle sprains, osteoarthritis of the knee, and shoulder pain. Its formulation is different from Mohrus Tape, which is available in Japan.
- Other names
- Ketoprofen PatchKetoprofen Transdermal Patch
02
Targets
COX
Beyond the preview
Go deeper on HKT-500.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HKT-500.